Minerva Neurosciences
NERV • NASDAQ
Minerva Neurosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Remy Luthringer, with a market cap of $267.4M.
CEORemy Luthringer
Next Earnings
Upcoming earnings announcement for Minerva Neurosciences
Date
Tuesday, May 12, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.14
Earnings History
Past 12 earnings reports for Minerva Neurosciences
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 11, 2026 | Q4 2025 | -$0.64Est: -$0.11 | -481.8% | - | — |  10-K |
| Nov 5, 2025 | Q3 2025 | -$0.36Est: -$0.35 | -2.9% | - | — | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.43Est: -$0.92 | +53.3% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.50Est: -$1.07 | +53.3% | - | — | 10-Q |
| Feb 25, 2025 | Q4 2024 | -$0.56Est: -$1.05 | +46.7% | - | — | 10-K/A |
| Nov 5, 2024 | Q3 2024 | $2.97Est: -$1.01 | +394.1% | - | — | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$1.09Est: -$0.97 | -12.4% | - | — | 10-Q |
| May 1, 2024 | Q1 2024 | -$1.13Est: -$1.20 | +5.8% | - | — | 10-Q |
| Feb 22, 2024 | Q4 2023 | -$1.19Est: -$0.88 | -35.2% | - | — | — |
| Nov 7, 2023 | Q3 2023 | -$1.03Est: -$0.77 | -33.8% | - | — | — |
| Aug 1, 2023 | Q2 2023 | -$1.12Est: -$0.44 | -154.5% | - | — | — |
| May 15, 2023 | Q1 2023 | -$1.31Est: -$1.63 | +19.6% | - | — | — |